Younger children between 5 and 11 years old could start getting the Pfizer-BioNTech coronavirus vaccine as soon as early November.

The data comes as the Food and Drug Administration enters the final stages of reviewing Pfizer's application to offer its shot to 5- to 11-year-olds.

Current COVID-19 vaccines and booster shots may not be enough to protect against future variants of the coronavirus, Ugur Sahin told the FT.

The antiviral drug could put a dent into the uptake of COVID-19 vaccines, as countries still struggle to reach herd immunity due to vaccine hesitancy.

The hope is that booster shots will help protect those most at risk as the pandemic continues to rage.

Six studies suggest vaccines from Pfizer, Moderna, and AstraZeneca work against the Delta variant, to varying degrees. Here's what the data shows.

Pfizer's COVID-19 vaccine got full FDA approval on Monday, including of its official name, Comirnaty - a combination of several words.

The vaccine will be marketed under the brand name Comirnaty, and the FDA hopes the approval will nudge unvaccinated people to get vaccinated.

The EU's drug regulator is looking at reports about skin rash and kidney problems.

Vaccine demand is likely to persist well into next year, the company said, with more than a billion doses still left to be delivered in 2022 and beyond.

Moderna and BioNTech have climbed in recent weeks as the resurgent Delta variant has captured headlines.

Israeli health officials said they'd seen protection against severe illness from Pfizer's vaccine decrease from 97% to 81% over time.

It's not yet clear how changes in immune response relate to the protection you get from Pfizer's COVID-19 vaccine.

One dose of Pfizer or Moderna vaccines appears at least 80% effective against symptomatic COVID-19. For AstraZeneca, one-shot efficacy is 70%.

Some experts, fearing Delta, are having Pfizer booster shots after J&J's one-dose vaccine. "We shouldn't wait" for official recommendations, one said.

Antibodies are one aspect of the immune response. It's not clear how well Pfizer's vaccine works against the Delta variant from India in real-life.

New York's "Get a Shot to Make Your Future" prize draw would allow parents of vaccinated 12 to 17-year-olds to add their child's names to a raffle.